论文部分内容阅读
目的观察米索前列醇联合缩宫素在治疗子宫收缩乏力性产后出血过程中的临床效果。方法将2014年12月~2015年12月期间在我院接受子宫收缩乏力性产后出血治疗的产妇76例作为实验研究的对象,按照其治疗的意愿将其分为观察组(n=38)和对照组(n=38),观察组患者给予米索前列醇联合缩宫素治疗,对照组患者给予单纯缩宫素治疗。结果观察组产妇与对照组产妇相比在临床治疗效果以及用药2小时后出血量情况上均存在着明显差异,具有统计学意义(P<0.05)。结论在对子宫收缩乏力性产后出血产妇实施治疗的过程中,米索前列醇联合缩宫素的运用可以减少患者用药后的出血量,改善患者的临床体征,促进患者的更好恢复,是一种效果理想且显著的治疗方案,值得予以临床推广和运用。
Objective To observe the clinical effect of misoprostol combined with oxytocin in the treatment of postpartum hemorrhage due to uterine atony. Methods Totally 76 maternal women who underwent uterine atony in our hospital from December 2014 to December 2015 were selected as experimental subjects and divided into observation group (n = 38) and control group In the control group (n = 38), patients in the observation group were given misoprostol combined with oxytocin and those in the control group were treated with oxytocin alone. Results Compared with the control group, maternal women in the observation group showed significant difference in the clinical treatment effect and the amount of bleeding after 2 hours of treatment, with statistical significance (P <0.05). Conclusions During the treatment of postpartum hemorrhage in women with uterine atony, the combination of misoprostol and oxytocin can reduce the amount of bleeding, improve the clinical signs and improve the recovery of patients The effect of the ideal and significant treatment options, it is worth to be clinical promotion and use.